Efficacy and Safety of Early Use of Everolimus in Standard and Extended Criteria Deceased Donor KidneyTransplant Recipients: 12-Month Preliminary Results of a Randomized Single Center Trial.

被引：0
|
作者：
Fernandes-Charpiot, I. [1 ,2 ]
Caldas, H. [2 ]
Mazeti, C. [2 ]
Baptista, M. [1 ,2 ]
Razera, J. [2 ]
Abbud-Filho, M. [1 ,2 ,3 ]
机构：
[1] Sao Jose do Rio Preto, Hosp Base, Fac Med, Sao Paulo, Brazil
[2] Sao Jose do Rio Preto, Lab Imunolgia & Transplante Expt, Sao Paulo, Brazil
[3] Sao Jose do Rio Preto, Inst Urol & Nefrol, Sao Paulo, Brazil
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1859
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Weekly Liquid Alendronate Sodium Trihydrate in Korean Postmenopausal Women with Osteoporosis: A 12-Month, Multi-Center, Randomized Trial
    Rhee, Y.
    Ahn, S.
    Hong, N.
    Seo, D.
    Hong, S.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 : A221 - A221
  • [22] EFFICACY OF TWO LONG-TERM EXERCISE PROGRAMS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: RESULTS OF 12-MONTH RANDOMIZED CONTROLLED TRIAL
    Orlova, E.
    Karateev, D.
    Denisov, L.
    Kochetkov, A.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 893 - 894
  • [23] A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients - Preliminary results
    Machado, PGP
    Garcia, C
    Felipe, CR
    Garcia, R
    Franco, M
    Delcelo, R
    Silva, HT
    Medina, JOP
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1074 - 1075
  • [24] Extended-Release Tacrolimus Plus Everolimus vs Extended-Release Tacrolimus Plus Micophenolate Mofetil in Primary Deceased Donor Kidney Transplant Recipients: 1-Year Results of an Open Label, Randomized Phase 2 Clinical Trial.
    Favi, E.
    Silvestrini, N.
    Pedroso, J.
    Salerno, M.
    Spagnoletti, G.
    Bianchi, V.
    Romagnoli, J.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 316 - 316
  • [25] Safety and Efficacy Profile of Everolimus With Reduced Tacrolimus in Living Donor Liver Transplant Recipients-12-month Results From the Pivotal H2307 Study
    Maluf, Daniel
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder S.
    Lee, Wei Chen
    Emond, Jean
    Lim, Kieron B.
    Lopez, Patricia M.
    Kochuparampil, Jossy
    Sips, Carole A.
    Kaneko, Shuhei
    Grant, David
    HEPATOLOGY, 2017, 66 : 901A - 901A
  • [26] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS AND EARLY STEROID ELIMINATION REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH DATA FROM THE CRADLE STUDY.
    Toenshoff, B.
    Ettenger, R.
    Christian, M.
    Bjerre, A.
    Strologo, L. D.
    Marks, S. D.
    Pape, L.
    Martzloff, E-D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 1 - 1
  • [27] Sirolimus/steroids Maintenance Therapy after Early Cyclosporine Withdrawal: 12-month Efficacy and Safety Results of Multicenter Single Arm Pilot Study in Primary Renal Allograft Recipients in Korea
    Ju, Man Ki
    Han, Duck-Jong
    Kim, Soo Jin
    Moon, In Sung
    Kim, Yong Lim
    Kim, Hyun Chul
    Kim, Seong Joo
    Kim, Sang Joon
    Kim, Soon Il
    Kim, Yeong Hoon
    Oh, Chang Kwon
    Kim, Yu Seun
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 79 (04): : 261 - 266
  • [28] Effect of Early Attainment of Everolimus Target Trough Levels on Efficacy-Safety Outcomes in De Novo Kidney Transplant Recipients: 12-Month Results from US92 and TRANSFORM Studies.
    Shihab, F.
    Qazi, Y.
    Peddi, V.
    Shaffer, D.
    Kim, D.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 259 - 259
  • [29] A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study
    Ramsay, Sophie
    Naud, Elizabeth
    Simonyan, David
    Moore, Katherine
    Bolduc, Stephane
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (06): : 192 - 198
  • [30] Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D. Y.
    Luan, F. L.
    Peddi, V. R.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (05) : 1358 - 1369
12345